Echoiq Limited has released a press release.
Strong Operational Momentum
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from EchoIQ
- Update on Category III CPT Code Application
- Preliminary Final Report
- Quarterly Activities & Appendix 4C Cashflow Reports
- Reseller Agreement Secured with SARC MedIQ
- Mayo Clinic Validation Study Underway
Later from EchoIQ
- Pause in Trading
- Trading Halt
- Category III CPT code application update
- Quarterly Activities and Appendix 4C Cash Flow Report
- Echo IQ Highlights Market Potential for EchoSolv AS Following Presentation of New Data for Severe Aortic Stenosis (AS) Presented at AHA Scientific Sessions 2025
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ